UK says monkeypox vaccine is ‘78% effective’


The UK Health Security Agency said its latest analysis “gives an estimate of vaccine effectiveness for a single dose of 78 per cent 14 or more days after vaccination”.

It described the findings as “the strongest UK evidence to date” for the jab’s effectiveness.

Denmark’s Bavarian Nordic is the only laboratory producing an approved monkeypox vaccine called MVA-BN.

It said last week it had signed a deal to supply European countries with up to two million doses of the jab.

See also  Same-sex marriage faces Senate test with uncertain GOP votes

More than 55,000 vaccine doses have been administered in England, said the NHS’s national director of vaccinations and screening, Steve Russell.

“We now know how effective the vaccine is, providing 78 percent protection against the virus with just one dose.”

The latest monkeypox outbreak began to spread around the world in May and peaked in July.

The UKHSA said its findings were based on analysis of 363 cases of monkeypox between July and November in England.

See also  On The Money — Senators are leading the fire on FTX

Most cases are among gay and bisexual men and others who have sex with men. Of those who contracted the virus, 323 were unvaccinated.

“We now know that a single dose of vaccine provides strong protection against monkeypox, demonstrating the importance of vaccination to protect yourself and others,” said Jamie Lopez-Bernal, an epidemiologist consultant at UKHSA.

“A second dose is expected to provide even greater and longer-lasting protection,” he added.

See also  Fallen trees close roads in Hamilton

The UK has had 3,570 confirmed cases of monkeypox, which causes fever, muscle aches and large boils.

The post UK Says Monkeypox Vaccine ‘78% Effective’ appeared first on UKTN.


Please enter your comment!
Please enter your name here